Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseHematopoietic Stem CellsTransplantation ConditioningTransplantation, AutologousStem Cell TransplantationBone MarrowWhole-Body IrradiationBone Marrow CellsTransplantation ChimeraLeukemiaHematologic NeoplasmsTissue DonorsBusulfanGraft SurvivalAnemia, AplasticHistocompatibility TestingHistocompatibilityRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositivePeripheral Blood Stem Cell TransplantationGraft vs Tumor EffectGraft vs Leukemia EffectStem CellsTreatment OutcomeHematopoiesisRemission InductionLeukemia, Myeloid, AcuteCyclophosphamideHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressive AgentsLiver TransplantationLeukocyte TransfusionCombined Modality TherapyLymphocyte DepletionLymphocyte TransfusionTransplantation, IsogeneicRetrospective StudiesMice, Inbred C57BLMyelodysplastic SyndromesAcute DiseaseTime FactorsRadiation ChimeraTransplantation ImmunologyHLA AntigensHematologic DiseasesLeukemia, MyeloidT-LymphocytesSurvival AnalysisImmunosuppressionCord Blood Stem Cell TransplantationGraft vs Host ReactionAntigens, CD34Graft RejectionHematopoietic Stem Cell MobilizationCytomegalovirus InfectionsSevere Combined ImmunodeficiencySurvival RateChimerismBone Marrow PurgingMyeloablative AgonistsDisease-Free SurvivalKidney TransplantationCyclosporineMultiple MyelomaCell DifferentiationChimeraBone and BonesLymphoma, Non-HodgkinNuclear FamilyFlow CytometryGranulocyte Colony-Stimulating FactorAntineoplastic Combined Chemotherapy ProtocolsFatal OutcomeFollow-Up StudiesCytarabineColony-Forming Units AssayAntilymphocyte SerumSalvage TherapyCell TransplantationMelphalanActuarial AnalysisMesenchymal Stem Cell TransplantationImmunocompromised HostCell LineageMice, Inbred BALB CInfectionPrognosisNeoplasm, ResidualCells, CulturedSiblingsHeart TransplantationBone Marrow DiseasesVidarabinePancytopeniaCell SeparationMinor Histocompatibility Antigens